by Chris Bartlett | Mar 2, 2022 | Biologics Manufacturing
Cleanroom Technology Feb. 22 article: we will explore a handful of common bioreactors and cleanroom organisms in terms of why they are able to proliferate and persist despite thorough Quality by Design (QbD) developed methods of production.
by LexaGene | Feb 1, 2022 | Veterinary Diagnostics
Dr. Jack Regan, CEO and Founder of LexaGene gives an update to BioPub Investment group on January 26, 2021.
by LexaGene | Oct 1, 2021 | Human Clinical Diagnostics
Dr. Jack Regan, CEO of LexaGene, shares his work identifying the future biothreats human and veterinary populations may face.
by LexaGene | Sep 16, 2021 | Biothreat Detection
GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army.
by LexaGene | Jul 22, 2021 | Human Clinical Diagnostics
In the latest issue of the Pathologist, Dr. Jack Regan discusses the strategic priorities and technologies that could prevent the next global pandemic: